HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 68, Number 5, January 30, 2007 Data Supplement All Versions of this Article: 01.wnl.0000247740.47667.03v1 68/5/384    most recent Correspondence: Submit a response Correspondence: View responses Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dorsey, E. R. Articles by Tanner, C. M. Search for Related Content PubMed PubMed Citation Articles by Dorsey, E. R. Articles by Tanner, C. M. Related Collections Parkinson's disease/Parkinsonism All epidemiology

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

From the Department of Neurology (E.R.D., R.C., K.M.B., R.G.H., K.K., F.J.M., B.M.R., G.S.), University of Rochester Medical Center, and School of Public Health (J.P.T.), University of Rochester, NY, Department of Neurology (A.S.), University of Pennsylvania Medical Center, Philadelphia, PA, and Parkinson’s Institute (C.M.T.), Sunnyvale, CA is currently with the Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden.

Address correspondence and reprint requests to Dr. Ray Dorsey, University of Rochester Medical Center, 1351 Mt. Hope Blvd., Suite 223, Rochester, NY 14620; e-mail: ray.dorsey{at}ctcc.rochester.edu

Based on published prevalence studies, we used two different methodologies to project the number of individuals with Parkinson disease (PD) in Western Europe’s 5 most and the world’s 10 most populous nations. The number of individuals with PD over age 50 in these countries was between 4.1 and 4.6 million in 2005 and will double to between 8.7 and 9.3 million by 2030.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down the Table of Contents for the January 30 issue to find the title link for this article.

This article was previously published in electronic format as an Expedited E-Pub on November 2, 2006, at www.neurology.org.

Disclosure: Dr. Dorsey is a strategic advisor to Avid Radiopharmaceuticals, Inc., and has received monetary compensation in excess of $10,000 and stock options. Avid Radiopharmaceuticals had no role in the analysis, preparation, or submission of this article.

Received February 20, 2006. Accepted in final form August 28, 2006.

See also pages 326 and 338

This article has been cited by other articles:

				C. Marras and A. Lang Invited Article: Changing concepts in Parkinson disease: Moving beyond the Decade of the Brain Neurology, May 20, 2008; 70(21): 1996 - 2003. [Abstract] [Full Text] [PDF]

				S. M. Albert Projecting neurologic disease burden: Difficult but critical Neurology, January 30, 2007; 68(5): 322 - 323. [Full Text] [PDF]

Correspondence: